144 related articles for article (PubMed ID: 16999728)
1. Persistent pure red cell aplasia due to parvovirus B19 infection in a patient with Turner's syndrome.
Pitchaipillai S; Kelsey P; Haeney M
Clin Lab Haematol; 2006 Oct; 28(5):347-50. PubMed ID: 16999728
[No Abstract] [Full Text] [Related]
2. Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1. Recovery with alpha-interferon therapy.
Martins A; Costa A; Oliveira MJ; Rodrigues M; Ribeiro AP; Silvestre F; Reis A
Sangre (Barc); 1998 Feb; 43(1):67-9. PubMed ID: 9577184
[TBL] [Abstract][Full Text] [Related]
3. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
[TBL] [Abstract][Full Text] [Related]
5. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
Kishore J; Mukhopadhyay C
Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
[TBL] [Abstract][Full Text] [Related]
6. Significant decrease in hemoglobin and hematocrit levels in a virologically controlled HIV-infected patient. Pure red cell aplasia (PRCA) caused by human parvovirus B19.
Naval-Srinivas RM; Church LW
AIDS Read; 2003 Apr; 13(4):189. PubMed ID: 12741369
[No Abstract] [Full Text] [Related]
7. In vitro erythroid effects of human stem cell factor in a case of human immunodeficiency virus-related chronic parvovirus B19 induced anemia.
Liesveld JL; Weissbach NE; Shafer JA; Abboud CN
Hematol Pathol; 1993; 7(1):23-32. PubMed ID: 7682213
[TBL] [Abstract][Full Text] [Related]
8. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.
Hayes-Lattin B; Seipel TJ; Gatter K; Heinrich MC; Maziarz RT
Am J Hematol; 2004 Mar; 75(3):142-5. PubMed ID: 14978694
[TBL] [Abstract][Full Text] [Related]
9. [Familial transient red cell aplasia from parvovirus B-19 infection].
Salvini F; Tonella M; Carpani G; Scaglioni S; Zuccotti GV
Pediatr Med Chir; 2002; 24(4):306-7. PubMed ID: 12197091
[TBL] [Abstract][Full Text] [Related]
10. Erythroblastopenia and Parvovirus B19 infection in a healthy child.
de Las Nieves López MA ; Medina Perez Mf ; Gónzalez Hermoso C
Haematologica; 2000; 85(E-letters):E07. PubMed ID: 11114822
[No Abstract] [Full Text] [Related]
11. Chronic human parvovirus B19 infection associated with interstitial lung disease.
Klar A; Halamish A; Shoseyov D; Cassinotti P; Siegl G; Springer C; Shazberg G; Hurvitz H
Isr Med Assoc J; 2002 Oct; 4(10):825-6. PubMed ID: 12389353
[No Abstract] [Full Text] [Related]
12. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
Ahsan N; Holman MJ; Gocke CD; Groff JA; Yang HC
Clin Transplant; 1997 Aug; 11(4):265-70. PubMed ID: 9267713
[TBL] [Abstract][Full Text] [Related]
13. Chronic pure red cell aplasia associated with parvovirus B19 infection in an immunocompetent patient.
Lugassy G
Am J Hematol; 2002 Nov; 71(3):238-9. PubMed ID: 12410591
[No Abstract] [Full Text] [Related]
14. Red cell aplasia associated with human parvovirus B19 and HIV infection: failure to respond clinically to intravenous.
Bowman CA; Cohen BJ; Norfolk DR; Lacey CJ
AIDS; 1990 Oct; 4(10):1038-9. PubMed ID: 2175617
[No Abstract] [Full Text] [Related]
15. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.
Kurtzman G; Frickhofen N; Kimball J; Jenkins DW; Nienhuis AW; Young NS
N Engl J Med; 1989 Aug; 321(8):519-23. PubMed ID: 2548098
[No Abstract] [Full Text] [Related]
16. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.
Plentz A; Hahn J; Holler E; Jilg W; Modrow S
J Clin Virol; 2004 Sep; 31(1):16-9. PubMed ID: 15288608
[TBL] [Abstract][Full Text] [Related]
17. Haematological consequences of parvovirus B19 infection.
Brown KE
Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):245-59. PubMed ID: 10942624
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous recovery from severe parvovirus B19 pure red cell aplasia, in a heart transplant recipient, as demonstrated by marrow culture.
Amiot L; Langanay T; Drénou B; Lelong B; Le Prisé PY; Logeais Y; Colimon R; Fauchet R
Hematol Cell Ther; 1998 Apr; 40(2):71-3. PubMed ID: 9615250
[TBL] [Abstract][Full Text] [Related]
19. Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy.
Mylonakis E; Dickinson BP; Mileno MD; Flanigan T; Schiffman FJ; Mega A; Rich JD
Am J Hematol; 1999 Feb; 60(2):164-6. PubMed ID: 9929113
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.
Hayakawa F; Imada K; Towatari M; Saito H
Br J Haematol; 2002 Sep; 118(4):1187-9. PubMed ID: 12199806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
